robot hand

Perspectives

AI in pharma and life sciences

Discover how AI is transforming pharma

What's the new currency for biopharma and life sciences companies? Two words: big data. Take a closer look at how artificial intelligence in the pharmaceutical industry is being used to mine insights from multiple data sets and make it interoperable across the enterprise. AI in supply chain and manufacturing is helping to reshape the pharma value chain and bring life-saving therapies to market faster.

From molecule to market: The use of AI in life sciences

We now live in the Age of With, in which AI doesn’t compete with human endeavors—it elevates them. And nowhere are its applications more remarkable than in life sciences, where digital transformation enabled by AI and machine learning is affecting virtually every aspect of the value chain and bringing us closer to the Future of Health. Applying AI to big data in life sciences can help companies reshape business models, streamline biopharma manufacturing, and enhance everything from cognitive molecule research and clinical trial data flow, to self-healing supply chain applications and product intelligence. It can also enable life sciences companies to be more personalized and authentic in how they engage with health care professionals, patients, and other stakeholders.

How? When used by the pharmaceutical industry, artificial intelligence can draw insights from massive data sets faster, process data and automate workflows more efficiently, and convert insights into actions to improve business performance.

Explore how you can capture the impact of AI at every stage of the pharma value chain, from molecule to market.

This section is an infogram

This message and the space it occupies will not be displayed when viewing this page either in Live, Preview, or "View as published" modes

How AI can transform the pharma value chain

${tab-1-img-alt}

Cognitive molecule research

AI is transforming R&D by applying data science and machine learning to massive data sets, enabling rapid discovery of new molecules. AI in drug discovery can cross-reference published scientific literature with alternative information sources, including clinical trial information, conference abstracts, public databases, and unpublished data, to surface promising therapies. Capabilities such as these have already delivered new candidate medicines—sometimes in months rather than years—and can help kick-start R&D productivity across the entire process.


Read our insights on this topic

${tab-2-img-alt}

Automated digital data flow

When used to automate clinical trials, AI can significantly reduce cycle times and costs, while also improving the outcomes of clinical development. In fact, AI and machine learning are already being deployed by life sciences companies to automatically generate artifacts, such as, study protocols, and leverage natural language processing to accelerate manual tasks. AI algorithms, combined with an effective digital infrastructure, can also enable continuous streams of clinical trial data to be cleaned, aggregated, coded, stored, and managed. The big takeaway? Applications of AI could lead to faster, safer, and significantly less expensive clinical trials.


Learn how Deloitte can help you automate clinical trial data flow


Read our latest blog on how AI can help accelerate clinical trials

${tab-3-img-alt}

Intelligent manufacturing and supply chain

Applying AI to biopharma manufacturing facilities and processes enables life sciences companies to stream factory and sensor data to analytics engines that generate novel insights. These insights can then help companies predict process bottlenecks, identify quality control issues, and proactively suggest corrective actions. Companies can also use AI to better predict demand and supply, recommend the next best action to supply chain operators, and even autonomously perform certain activities. Delivering on the grand vision of Biopharma 4.0, these “self-healing” supply chain tools can improve companies’ ability to dynamically respond to changes in market demand and supply availability, minimize disruptions, and improve decision-making related to product distribution and new product introductions.


Learn how Deloitte can help you improve manufacturing yield and product quality.


Find out how Deloitte can help you leverage AI for product development and enhancement.

${tab-4-img-alt}

Personalized customer and patient engagement

Smarter, actionable insights. It’s what all biopharma commercial and brand leaders are after—and AI has the power to deliver. Patient journeys, advertising metrics, and HCP data can be combined and analyzed with AI to improve omnichannel marketing messaging and channels. In fact, dynamic personalization and engagement of HCPs can be customized based on insights from rich data sets and patterns. AI can even provide recommendations to marketing and sales reps on next best actions, channels, and personalized content. But the benefits of this approach stretch beyond marketing. It can also be used to analyze patient feedback and complaints, medical inquiries, and social media data to incorporate the voice of the patient into product iterations.


Learn how data and AI can power marketing intelligence

${tab-5-img-alt}

Automated, evidence-based safety intelligence

Millions of adverse events are reported each year, and the volume is growing by about 10%- to 15% annually, compounded by data generated from new sources, such as wearables and social media. Processing these adverse event reports is a manual, costly, and often decentralized process that can jeopardize compliance with safety regulations and prevent early discovery. But automating and centralizing the intake of adverse event reports—leveraging AI-enabled technologies such as optical character recognition and natural language processing—can reduce case documentation workload to significantly expedite the investigation process. In fact, decreased manual effort can potentially lead to significant productivity savings, resulting in millions of dollars in savings.


Find out how you can transform Pharmacovigilance with ConvergeHEALTH Safety

${tab-6-img-alt}

Intelligent threat intelligence, response, and recovery

The cyber threat landscape is growing exponentially. Insider threats are learning to evade signature-based systems, and bad actors are using AI to avoid detection by learning the most common detection rules. Smart cyber technologies will be increasingly needed to protect the growing volume of data biopharma companies own and can access. AI-based approaches can improve threat intelligence and prediction, and enable faster attack detection and response, augmenting efforts by cybersecurity experts.

Future of Work: Ways of working in uncertain times

AI solutions for life sciences

Solutions, capabilities, and assets Deloitte offers across the life sciences value chain.

The Lifesciences & Healthcare Dossier

Explore our compelling, business-ready use cases for AI in life sciences and health care.

The Deloitte AI Institute

Discover how the AI Institute helps organizations transform through cutting-edge innovation by bringing together the brightest minds in AI to advance human-machine collaboration in the Age of With™.

Deloitte can help you use AI in pharma to predict what’s possible and translate it into business performance -- from molecule to market.

Deloitte is collaborating with a broad range of life sciences companies to innovate with AI, analytics, and data technologies that help identify unique advantages with greater accuracy, bring urgently needed therapies to market faster, and more effectively reach patients.

We offer a full suite of capabilities and assets across the full life sciences value chain, including CortexAI™ , a cloud-agnostic AI development platform with plug-and-play technologies for data, analytics, intelligent automation, and machine learning. We can help expand your company’s AI capabilities at speed and scale. And we bring unparalleled breadth, depth, and a wealth of industry experiences and therapy areas to draw from. Through a business lens, we can also help companies weigh ethical considerations, responsibility, assurance, and accountability.

 

 

Explore our AI solutions for life sciences

Learn more

Access our latest thinking

Select a category:
Close
Cross Value Chain
Scaling up AI across the life sciences value chain
Enhancing R&D, creating efficiencies, and increasing impact
Close
Cross Value Chain
COVID-19 highlighted AI’s potential in life sciences
Health Forward blog
Close
Cross Value Chain
Intelligent biopharma
Forging the links across the value chain
Close
Cross Value Chain
The Future of Health™
How innovation will blur traditional health care boundaries
Close
Solutions
AI innovation in the Age of With™
Advancing AI innovation and human-machine collaboration
Close
Cross Value Chain
Deloitte AI Institute
Connecting you to the different dimensions of the AI ecosystem
false
Close
Drug Discovery
Intelligent drug discovery
Powered by AI
false
Close
Clinical trials
Intelligent clinical trials
Transforming through AI-enabled engagement
false
Close
Cross Value Chain
J&J CIO: Embed Data Science Across the Enterprise
CIO Insights and Analysis from Deloitte
false
Close
Operations
Intelligent drug supply chain
false
Close
Operations
Smart Factory for Smart Manufacturing
Start the journey with scalable smart factory solutions
false
Close
Operations
The biopharma smart factory of the future
Innovations in biopharmaceutical manufacturing
false
Close
Operations
The digital edge in life sciences
The business case for digital supply networks
false
Close
Safety
Transforming pharmacovigilance systems
Using technology, analytics, and automation to enable next-gen patient safety
false
Close
Cyber
Smart cyber
How AI can manage cyber risk
false

Connect. Converge. Cure.

ConvergeHEALTH creates new health ecosystems to enable the future of health by combining next-generation platforms, deep industry experience, and novel collaboration models that empower the shift to value-based, personalized health care.

Learn more >

This section is an infogram

This message and the space it occupies will not be displayed when viewing this page either in Live, Preview, or "View as published" modes

Did you find this useful?